Acentia announces acquisition of Business Computer Applications

Acentia, a premier provider of technology and management solutions, today announced it has acquired Atlanta-based Business Computer Applications, Inc. (BCA), a provider of information technology (IT) services and solutions to the Centers for Disease Control and Prevention (CDC) and other health agencies.

For nearly 40 years, BCA served the CDC, National Institutes of Health (NIH), and the Health Resources & Services Agency (HRSA), by promoting efficiencies and modernizing infrastructures through innovative solutions.

The acquisition of BCA significantly expands Acentia's presence in the Health IT market through the addition of the CIMS Information Management Services Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle.

"Acentia's strategic goals are simple—providing innovative solutions to help the CDC and other health agencies meet their mission-critical public health and other priorities," said Acentia CEO Todd Stottlemyer. "The acquisition of BCA supports these goals by providing us with a critical contract vehicle, CIMS, which allows us to compete for important full and open work with the CDC. Additionally, merging BCA's capabilities, relationships, and domain expertise strengthens our technical capabilities and past performance with the CDC and our public sector health customers."

More than 30 employees located in Atlanta and Hyattsville, Md., will join Acentia's 1,100-strong workforce.

Acentia's Health IT customers include the CDC, the Centers for Medicare and Medicaid Services (CMS), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the Defense Health Agency (DHA).

Source:

Acentia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing Adherent Cell Assays with SemaCyte® Technology